Branning Todd P. Insider Trades

Insider Trading History

Track insider trading activity for Branning Todd P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $31.8k 84,200 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.33M 54,200 shares
$79.92
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $75.6k 200,000 shares
Last Trade
Nov 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2M 200,000 shares
$110.76
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $11.3k 30,000 shares
Last Trade
Mar 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.28M 10,000 shares
$728.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $7.56k 20,000 shares
Last Trade
Mar 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13M 20,000 shares
$652.00
$0.38
NeuBase Therapeutics
NeuBase Therapeutics NBSE
Chief Financial Officer
Holding Value $113k 300,000 shares
Last Trade
Jan 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302M 300,000 shares
$1,008.00
$0.38
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Chief Financial Officer
Holding Value $592k 60,000 shares
Last Trade
Jan 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.35M 60,000 shares
$39.11
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Chief Financial Officer
Holding Value $838k 85,000 shares
Last Trade
Jul 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 85,000 shares
$29.43
$9.86
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
SVP And CFO
Holding Value $173k 12,785 shares
Last Trade
Jan 22, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.5k 7,311 shares
$5.13
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
SVP And CFO
Holding Value $272k 20,096 shares
Last Trade
Jan 22, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103k 20,096 shares
$5.13
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
SVP And CFO
Holding Value $815k 60,290 shares
Last Trade
Jan 22, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103k 20,096 shares
$5.13
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
SVP And CFO
Holding Value $2.21M 163,666 shares
Last Trade
Nov 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$450k 163,666 shares
$2.75
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
SVP And CFO
Holding Value $0 0 shares
Last Trade
Nov 13, 2019 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$450k 163,666 shares
$2.75
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Svp, Chief Financial Officer
Holding Value $2.21M 163,666 shares
Last Trade
Jan 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04M 244,052 shares
$12.44
$13.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up